Midazolam Injection
Product Images NDC 0404-9913

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 0404-9913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of Midazolam represented with rings, nitrogen, chlorine, fluorine atoms, and a hydrochloride component, depicting the molecular arrangement of this active ingredient.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram showing Midazolam and its open-ring form. The diagram illustrates the reversible chemical structures with labeled functional groups, including methyl, chlorine, fluorine, and amino groups, highlighting the ring opening mechanism of Midazolam.*

FDA Label Image

Image1.jpg (Image1)

A line graph titled 'pH Dependence of Open-ring Form in Water' showing the percentage of open-ring form on the vertical axis and pH on the horizontal axis. The data points indicate a steep decrease in the percentage of open-ring form as pH increases from approximately 2.5 to 5.5.*

FDA Label Image

Image2.jpg (Image2)

A partial text panel listing local side effects related to intramuscular injection, including pain (3.7%), induration (0.5%), redness (0.5%), and muscle stiffness (0.3%). The text also mentions headache (1.3%) among other effects.*

FDA Label Image

Image3.jpg (Image3)

A Drug Facts panel excerpt showing percentages of reported side effects, including hiccoughs (3.9%), nausea (2.8%), vomiting (2.6%), coughing (1.3%), headache (1.5%), drowsiness (1.2%), and local effects at the intravenous site such as tenderness (5.6%), pain on injection (5.0%), redness (2.6%), induration (1.7%), and phlebitis (0.4%).*

FDA Label Image

Image4.jpg (Image4)

This text panel provides dosing and administration information for Midazolam 1 mg/mL injection by Henry Schein, Inc., for intramuscular and intravenous use in adults. It details dosing recommendations, adjustments for specific conditions, and cautions related to respiratory depression, emphasizing individualized dosing and monitoring requirements.*

FDA Label Image

Image5.jpg (Image5)

A text panel providing detailed drug information for Midazolam injection 1 mg/mL by Henry Schein, Inc. It includes dosing guidelines for anesthesia induction, continuous infusion, and pediatric use, as well as warnings and contraindications, including responses and assessments related to sedation and alertness during procedural sedation with midazolam. The panel also covers adverse reactions, dosage adjustments, and detailed patient assessment criteria for clinical use.*

FDA Label Image

Image6.jpg (Image6)

This image shows prescribing information text for Midazolam injection 1 mg/mL by Henry Schein, Inc. It includes details on intramuscular, intravenous, and continuous intravenous infusion routes, focusing on dosage guidelines, usual pediatric dosing, and safety considerations in special care settings such as neonatal and intensive care. Warnings and administration notes are specified.*

FDA Label Image

Image7.jpg (Image7)

Table listing vials of midazolam hydrochloride injection by concentration and packaging. It details 1 mg/mL midazolam in 2 mL, 5 mL, and 10 mL vial sizes with corresponding NDC codes and 5 mg/mL midazolam in 1 mL, 2 mL, and 10 mL vial sizes with their respective NDC codes, including package quantities of 10s and 25s.*

FDA Label Image

Label1.jpg (Label1)

Midazolam injection label showing 5 mg/5 mL (1 mg/mL) vial for intramuscular or intravenous use. Label states it contains benzyl alcohol preservative and lists ingredients such as midazolam hydrochloride and sodium chloride. The label includes storage instructions, barcode, lot number, expiration, and manufacturer details for Henry Schein, Inc., Bastian, VA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.